{"title":"Association of antihypertensives and Parkinson’s disease in a primary care population matched for underlying diagnosis","link":"https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0299985","date":1710943200000,"content":"<p>by Anette Schrag, Karel Kostev</p>\r\nPurpose <p>To examine the association of several antihypertensive medication classes with incidence of Parkinson’s disease (PD), taking into account possible underlying conditions.</p> Methods <p>In a case-control study based on a large primary care database and including 21,981 PD cases and 21,981 non-PD controls matched for age, sex, and possible treatment indications associations with different antihypertensive medication groups, including diuretics, betablockers, calcium channel blockers, angiotensin-converting enzyme inhibitors and angiotensin-II receptor-blockers and PD were examined.</p> Results <p>Antihypertensive medications overall were associated with a lower risk of subsequent diagnosis of PD (OR: 0.94, 95% CI 0.90–0.97), with the negative association most significant for medications acting on the renin–angiotensin–aldosterone system. A positive association with diagnosis of PD was only seen for betablockers and restricted to those with relatively young age and not in those with longer treatment duration.</p> Conclusion <p>When taking into account underlying diagnoses, antihypertensive medications overall were associated with a reduced incidence of PD.</p>","author":"Anette Schrag","siteTitle":"PLOS ONE","siteHash":"e9ab556ceb1e4ea76e897a5fa4f394f0bb75c2c2f3d5b0f4766ff77b4a262ac1","entryHash":"3510fcbb3c0d177edaf1687188e510260967d5477d70aaaa856ad4c013d71452","category":"Interdisciplinary"}